在卵巢癌细胞中,olaparib通过上调miR-125a-3p来增加化学敏感性
Zehua Wang1,2, Tao Pu1,2, Weiwei Miao3
1Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
Discover oncology
|March 11, 2025
概括
齐斯普拉丁与olaparib治疗相结合,显著降低了小鼠的卵巢瘤体积. 这种组合疗法增加了miR-125a-3p的表达,增强了卵巢癌的治疗敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 卵巢癌在妇科瘤中死亡率最高.
- 包括olaparib在内的PARP抑制剂维护疗法是BRCA突变瘤的标准.
- 研究olaparib在非BRCA突变卵巢癌中的疗效和机制至关重要.
研究的目的:
- 评价单独和与思普拉丁联合使用的olaparib对非BRCA突变卵巢癌的影响.
- 阐明潜在的分子机制,重点关注微RNA (miRNA) 表达.
- 为了确定miR-125a-3p是否在治疗反应中起作用.
主要方法:
- 用裸体小鼠的卵巢癌皮下移植模型来评估抗瘤效应.
- 使用miRNA数组进行了miRNA表达特征分析.
- 在卵巢癌细胞中分析了细胞增殖,细胞周期,衰老和DNA损伤蛋白质表达.
主要成果:
- 西斯普拉丁加上奥拉巴里布在体内显著降低了瘤体积.
- 这种联合治疗导致了miR-125a-3p表达的显著增加.
- 过度表达miR-125a-3p抑制了细胞迁移和入侵,并诱导了细胞循环停止.
结论:
- 增加miR-125a-3p的表达有助于DNA损伤和卵巢癌细胞的衰老.
- 这种miRNA上调增强了卵巢癌对治疗的治疗敏感性.
- 这些发现表明,在非BRCA突变卵巢癌中,涉及miR-125a-3p调节的潜在治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:07Oogenesis
63.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.3K